Document is current
Any future updates will be listed below
-
Authors
San, Changmeng
Xu, Yongqing
Lee, Mingjun
Pu, Luqiao
Wang, Teng
Shi, Xiangwen
Lu, Siyu
Cheng, Qi
-
Funding
Funding for this research was provided by:
Yunnan Orthopaedic Trauma Clinical Medical Center (ZX20191001)
National Key Research and Development Program of China (2017YFC1103900)
- License Information
-
More Information
Article History
Received: 12 April 2022
Accepted: 1 November 2022
First Online: 22 December 2022
Declarations
:
: This study was approved by the Ethics Committee of the 920th Hospital of the Joint Logistics Support Force and by the Ethics Committee of Haiyuan College of Kunming Medical University, serial number: 伦审2021-064 (科) -02. The cadaver specimens used in the autopsy part of this experiment were legally provided by “Yunnan Pengyang Biotechnology Co., Ltd.” All the corpses were legally donated and authorized to be disposed of and used by the company. Our team signed an agreement with the company to authorize the use of these bodies. The experimental site was limited to the Department of Anatomy, Haiyuan College of Kunming Medical University, and the experimental process fully followed the relevant ethical requirements. The clinical investigators obtained informed consent from the patients and their families, informed the patients and their families of the possible risks and expected benefits of the modified quadratus femoris bone graft procedure, and obtained authorization from the patients and their families.
: Not applicable.
: The authors declare that they have no competing interests.
